Special Issue "The New Frontier in Pulmonary Fibrosis"
Deadline for manuscript submissions: 31 August 2019
Dr. Andrew J. Bryant
As you are aware, idiopathic pulmonary fibrosis (IPF) is an unrelenting and incurable disease characterized primarily by progressive stiffening and scarring of the lungs. In IPF, alveolar epithelial cell dysfunction and aberrant proliferation of activated fibroblasts—with contemporaneous vascular endothelial cell dysfunction—contribute to the development of alveolar thickening, which then leads to the formation of fibroblastic foci and the honeycombing of the lungs and, ultimately, respiratory failure and death. This Special Issue focuses on novel mechanisms, diagnostic techniques, and therapeutics contributing to IPF, including aberrant metabolic and immunologic responses to lung tissue regeneration, as well as frequent comorbidities seen in IPF such as pulmonary hypertension. We warmly welcome a broad assortment of submissions, including original papers and reviews, on the forefront of this stimulating topic.
Dr. Andrew J. Bryant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Pulmonary fibrosis
- Extracellular matrix
- Vascular endothelium
- Alveolar epithelial cell
- Lung immunology
- Respiratory physiology